When was NeuroEM founded?

NeuroEM was founded in 2013 and raised its 1st funding round 3 years after it was founded.

Where is NeuroEM located?

NeuroEM is headquartered in Tampa, United States.

How many employees does NeuroEM have?

As of Jul 01, 2024, the latest employee count at NeuroEM is 4.

Is NeuroEM a funded company?

NeuroEM is a funded company, having raised a total of $9M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Feb 19, 2016.

When was the latest funding round of NeuroEM?

NeuroEM's latest funding was a $***** Series A round on Apr 09, 2025, with participation from 0 investor.

Where does NeuroEM rank among its competitors?

NeuroEM ranks 42nd amongst 152 active competitors, of which 38 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Spark Biomedical, which secured an undisclosed amount in Aug, 2025.

Who are the top competitors of NeuroEM?

NeuroEM's top competitors include Ceribell, Cognito Therapeutics and Spark Biomedical. Among them, Spark Biomedical secured the most recent funding round in August, 2025.

NeuroEM - 2026 Company Profile, Funding & Competitors

NeuroEM is a series A company based in Tampa (United States), founded in 2013. It operates as a Developer of medical device a non-invasive treatment for cognitive decline. NeuroEM has raised $9M in funding from Bluelake. The company has 152 active competitors, including 38 funded and 3 that have exited. Its top competitors include companies like Ceribell, Cognito Therapeutics and Spark Biomedical.

Company Details

Developer of medical device a non-invasive treatment for cognitive decline. The company is pioneering the use of Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF) with its patented wearable device called MemorEM that delivers electromagnetic waves through a head cap to break up toxic proteins beta-amyloid and p-tau, which are believed to underlie Alzheimer's disease. As of July 2016, it has been tested in animals and has shown no adverse effects. Human trials have already began.

Key Metrics

Founded Year

2013

Location

Tampa, United States

Stage

Series A

Total Funding

$9M in 4 rounds

Latest Funding Round

Series A, Apr 09, 2025, $*****

Investors

Bluelake & 2 more

Ranked

42^nd among 152 active competitors

Employee Count

4 as on Jul 01, 2024

Similar Companies

Ceribell & 160 more

View NeuroEM's full profile

NeuroEM has raised a total funding of $9M over 4 rounds. Its first funding round was on Feb 19, 2016. NeuroEM has 3 institutional investors.

Here is the list of recent funding rounds of NeuroEM:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 09, 2025	6447481	Series A	7796356	5853883	4063705	1295528
May 31, 2024	6944700	Seed	2422526	5339630	3164047	9043330
Dec 15, 2016	8052709	Grant (prize money)	4040021	8276326	3309642	HHS

Access funding benchmarks and valuations. Sign up today!

View details of NeuroEM's funding rounds and investors

NeuroEM's employee count trend

NeuroEM has 4 employees as of Jul 24. Here is NeuroEM's employee count trend over the years:

Uncover NeuroEM's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuroEM include Ceribell, Cognito Therapeutics and Spark Biomedical. Here is the list of Top 10 competitors of NeuroEM, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ceribell 2014, Mountain View (United States), Public	EEG system for the diagnosis of seizures	$188M	The Rise Fund, Ally Bridge Group & 11 others	68/100
2nd	Cognito Therapeutics 2016, Cambridge (United States), Series C	Developer of a medical device for the treatment of Alzheimer's disease	$423M	Morningside, FoundersX Ventures & 5 others	62/100
3rd	Spark Biomedical 2018, Houston (United States), Series A	Developer of neurosimulation device for opioid withdrawal	$31.2M	Wave Ventures, Wellcome Leap & 5 others	55/100
4th	Cala Health 2013, Stanford (United States), Series D	Developer of a wearable non-invasive neuromodulation device	$207M	Novartis, Ascension Ventures & 27 others	55/100
5th	Kernel 2016, Los Angeles (United States), Series C	Developer of multimodal brain measurement technology for neuromedicine	$158M	General Catalyst, Khosla Ventures & 3 others	53/100
6th	Myndlift 2014, New York (United States), Seed	Provider of digital mental care and neurotherapy platform	-	New York Angels, 500 Global & 2 others	49/100
7th	Mendi 2017, Stockholm (Sweden), Seed	Provider of wearable brain training devices	$8.21M	First Venture, Gaingels & 8 others	49/100
8th	Brightmind.AI 2022, Vienna (Austria), Funding Raised	Provider of AI-based headset for brain simulation	-	BioVaria, xista	48/100
9th	Halo 2013, San Francisco (United States), Acquired	Online platform offering wearable brain cortex stimulator to improve exercise performance	$61.7M	TPG, Andreessen Horowitz & 13 others	47/100
10th	Sense Neuro Diagnostics 2013, Cincinnati (United States), Seed	Non-invasive brain activity monitoring device	$4.64M	Queen City Angels, Defense.gov & 3 others	47/100
42nd	NeuroEM 2013, Tampa (United States), Series A	Developer of medical device a non-invasive treatment for cognitive decline	$9M	New York Angels, HHS & 1 others	48/100